Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Clinical Knowledge Summaries (CKS)
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Life sciences
More from NICE
Home
NICE guidance
Topic prioritisation
Topic prioritisation
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic prioritisation
Filter (1 applied)
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Decision date
Decision date
From date
To date
Apply date filters
Prioritisation routing
Prioritisation routing
None selected (24)
Decision
Decision
Awaiting decision (3)
Further information required (2)
Not selected (18)
Apply filters
Showing 1 to 24 of 24
Sort by
Decision date
Title
Apply sorting
Keyword or reference number: cancer
Remove Keyword or reference number: cancer filter
Topic prioritisation
Title
Prioritisation routing
Decision
Decision date
Sentinel Node Biopsy approved for pathological staging of clinically T1-T2 N0 oral
cancer
None selected
Not selected
16 October 2025
Technologies to improve the detection of endometrial
cancer
None selected
Awaiting decision
10 September 2025
Subcutaneous pembrolizumab with platinum-based chemotherapy for untreated metastatic non-small-cell lung
cancer
[TSID12213]
None selected
Not selected
16 June 2025
Dostarlimab for previously treated advanced or recurrent endometrial
cancer
with high microsatellite instability or mismatch repair deficiency (MA review of TA779) [ID6326]
None selected
Awaiting decision
12 May 2025
Trastuzumab deruxtecan for treating HER2-positive unresectable or metastatic breast
cancer
after 1 or more anti-HER2 therapies (MA review TA704 and TA862) [ID5121]
None selected
Awaiting decision
7 January 2025
Henlius (pertuzumab biosimilar) for treating HER2-positive breast
cancer
[TS ID 12094]
None selected
Not selected
10 September 2024
Subcutaneous amivantamab for treating advanced non-small-cell lung
cancer
with EGFR mutations [TSID12011]
None selected
Not selected
21 May 2024
MRI-guided laser interstitial thermal therapy for early prostate
cancer
None selected
Not selected
28 September 2023
Percutaneous cryotherapy (PCT) for the therapy of primary lung
cancer
or metastatic lung
cancer
None selected
Not selected
4 September 2023
Use of a glue or sealant to achieve lung volume reduction in emphysema and lung
cancer
None selected
Not selected
27 July 2023
Perfusion-induced systemic hyperthermia for the treatment of advanced lung
cancer
None selected
Not selected
30 March 2023
Advanced Pelvic Exenteration surgery for complex pelvic
cancers
None selected
Not selected
23 February 2023
Bronchoscopic intrabullous autologous blood instillation (BIABI) for the therapy of Emphysema: intractable with pneumothorax, COPD & Lung
cancer
, patients requiring lung biopsy
None selected
Not selected
23 February 2023
Stockholm3 blood test for prostate
cancer
, (MT734),
None selected
Not selected
14 December 2022
Image-guided high intensity focused ultrasound to treat breast
cancer
None selected
Not selected
1 September 2022
Bladder EpiCheck for the detection of bladder
cancer
recurrence (MT706)
None selected
Further information required
25 May 2022
Electrically-stimulated intravesical chemotherapy for non-muscle invasive bladder
cancer
None selected
Further information required
19 May 2022
Prostate specific membrane antigen (PSMA) radiotherapy for treating advanced prostate
cancer
None selected
Not selected
3 March 2022
MT656 Paige Prostate AI system for the detection of prostate
cancer
None selected
Not selected
25 November 2021
trublood-prostate for triaging and diagnosing people with prostate
cancer
symptoms (MT604) (MIB268)
None selected
Not selected
30 September 2021
URO17 for testing suspected bladder
cancer
None selected
Not selected
6 May 2021
Archimedes for biopsy of suspected lung
cancer
None selected
Not selected
9 September 2020
Paclitaxel + XR17 (Paclical) with carboplatin for ovarian
cancer
[TSID5462]
None selected
Not selected
3 March 2011
Atezolizumab with cabozantinib for treating metastatic non-small-cell lung
cancer
after platinum-based chemotherapy and 1 PD-L1 checkpoint inhibitor TSID 11812
None selected
n/a
TBC
Current page
1
Page
1
of
1
Results per page
10
25
50
All
Back to top